Managed Access Agreements: A New Model Pathway For Reimbursement of Non-Oncology Drugs in England Approved Under European Adaptive Pathways?

Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

Previous Article
The Future of UK Drug Pricing: The 2014 PPRS - An Interim Review
The Future of UK Drug Pricing: The 2014 PPRS - An Interim Review

Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

Next Article
The UK Early Access to Medicines Scheme: A 2-Year Status Update On Success, Issues and Controversies
The UK Early Access to Medicines Scheme: A 2-Year Status Update On Success, Issues and Controversies

Educational poster presented at ISPOR 20th Annual European Congress, November 2017.